June 3, 2023
CHICAGO — New results in the treatment of advanced ovarian cancer have been welcomed by an expert not involved in the trial, even though the study […]
June 2, 2023
A board-certified New Jersey oncologist has pled guilty to using her medical license to purchase cancer medications under the false pretense that they would be used […]
June 2, 2023
CHICAGO —The combination of ribociclib (Kisqali) and endocrine therapy has already been shown to yield a significant survival advantage for women with metastatic, hormone receptor–positive, HER2-negative […]
June 1, 2023
Changes to primary endpoints in phase 3 cancer trials occur frequently and are often undisclosed in study manuscripts, new research shows. Among 755 randomized controlled cancer […]
June 1, 2023
The US Food and Drug Administration (FDA) has approved olaparib (Lynparza, AstraZeneca) with abiraterone and prednisone (or prednisolone) for BRCA-mutated metastatic castration-resistant prostate cancer, as determined […]
June 1, 2023
Paula Ngon, a 28-year-old public relations professional with Estée Lauder in New York, understands the value of good communication. After all, it’s her job to share […]
June 1, 2023
Radiation oncology clinics have been hit hard by clinical staff shortages, a recent national survey shows. The survey, conducted by the American Society for Radiation Oncology […]
May 31, 2023
The federal government is reconsidering a decision that breast cancer patients, plastic surgeons, and members of Congress have protested would limit women’s options for reconstructive surgery […]
May 31, 2023
French investigators are warning clinicians who treat patients with non–small cell lung cancer (NSCLC) not to initiate treatment with sotorasib within 30 days of an immunotherapy infusion […]